Regeneron Is A Biotechnology Company Founded In 1988 By Leonard Sschleifermdphdheadquartered In Tarrytownnew Yorkthe Company Is Dedicated To Inventingdevelopingand Commercializing Medicines For Serious Diseases Across Various Therapeutic Areasincluding Eye Diseasescancerand Rare Conditions The Company Utilizes Advanced Technologies Such As Velocisuiteafor Generating Human Antibodies And The Regeneron Genetics Centerato Leverage Genetic Data For Drug Developmentregeneron Has A Strong Portfolio Of Fda Approved Therapies And A Pipeline Of Investigational Drugsfocusing On Homegrown Candidatesits Leadership Includes Physician Scientists And Nobel Laureatesfostering A Culture Centered On Scientific Innovation Regeneron Collaborates With Academic Institutions And Other Companies To Enhance Research And Development Capabilitiesthe Company Aims To Make Its Medicines Accessible To Patients With Serious Conditionsemphasizing A Commitment To Addressing Unmet Medical Needs Through Strong Scientific Insights
